Dear Shareholders, We would like to express our sincere appreciation for your continued support. You are hereby notified that an Extraordinary General Meeting of Shareholders of the Company will be held as described below. In convening this General…
Dear Shareholders,
We would like to express our sincere appreciation for your continued support.
You are hereby notified that an Extraordinary General Meeting of Shareholders of the Company will be
held as described below.
In convening this General Meeting of Shareholders, the Company has taken measures for electronic
provision and has posted the matters subject to electronic provision on the website below under the title
"Notice of Convocation of the Extraordinary General Meeting of Shareholders."
The Company’s website:
(https://ir.amvis.com/ja/ir/stock/meeting.html)
In addition to the above, the matters are also posted on the following website.
Tokyo Stock Exchange Website:
(https://www2.jpx.co.jp/tseHpFront/JJK010010Action.do?Show=Show)
Please access the above website, enter and search for the Company name or securities code (7071),
and select "Basic Information" followed by "Documents for Public Inspection/PR Information" to view the
materials.
If you are unable to attend the meeting in person, you may exercise your voting rights in writing or via the
Internet. Please review the Reference Documents for the General Meeting of Shareholders included in
the matters subject to electronic provision, indicate your approval or disapproval on the enclosed Voting
Rights Exercise Form and return it so that it arrives no later than 6:00 p.m. on Thursday, November 12,
2026, or exercise your voting rights via the voting website (https://evote.tr.mufg.jp/).
Sincerely yours
Meeting Agenda
- Date and Time
Friday, November 13, 2026, 1:00 p.m. (JST)
(Reception desk will open at 12:30 p.m. (JST))
- Venue
Vision Center Tokyo Toranomon
Room 601C/D, 6F, T-LITE
2-4-7 Toranomon, Minato-ku, Tokyo
Please note that both the venue and starting time have changed from the Ordinary General Meeting of
Shareholders held last year.
- Agenda
Matters to be Resolved
Proposal No. 1
Proposal No. 2
Approval of the Absorption-type Company Split Agreement
Approval of the Subsidiary Share Transfer Agreement
1
[Notice Concerning Infectious Diseases]
In order to prevent the spread of infectious diseases, The General Meeting of Shareholders will be held
with appropriate measures in place to prevent the spread of infectious diseases.
We will take your temperature near the entrance of the venue, and if you are found to have a fever or
poor physical condition, you may be denied admission to the venue.
The operating staff of the General Meeting of Shareholders may be wearing masks. Thank you for your
understanding and cooperation.
- If you plan to attend the meeting, please submit the enclosed voting rights exercise form at the reception
desk. Please note that even if you bring the voting rights exercise form with you, people other than
shareholders who are entitled to exercise their voting rights, such as proxies or people accompanying
shareholders who are not shareholders, will not be admitted to the meeting (however, people
accompanying shareholders with disabilities, guide dogs, hearing dogs, service dogs, etc. will be
admitted).
- If any amendments are made to items subject to measures for electronic provision, the Company will
announce such amendments on the Company’s relevant website.
- If major changes occur in the operation of the General Meeting of Shareholders due to future
circumstances, the Company will announce them on the Company’s website.
(https://www.amvis.com/en/).
2
Reference Documents for the General Meeting of Shareholders
Proposals and Reference Matters
Proposal No. 1 Approval of the Absorption-type Company Split Agreement
(1) Reasons for Conducting the Absorption-type Company Split
The Group has developed Ishinkan residential facilities nationwide that proactively accept patients with
high medical care needs, including patients with terminal cancer, patients using ventilators, and patients
with severe neurodegenerative diseases. In cooperation with local medical institutions and other parties,
Ishinkan has provided a place to receive end-of-life nursing and long-term care.
To date, in addition to the Tokyo metropolitan area and eastern Japan, the Group has actively opened
facilities in new regions including western Japan. In light of differences in resident needs and acceptance
conditions by region, the Company has decided to place greater focus on operating Ishinkan facilities
that accept patients with high medical acuity and those nearing end of life, an area in which the Company
has particular strengths, and to allocate management resources primarily to the Tokyo metropolitan area
and eastern Japan, where those strengths can be more fully leveraged.
With respect to the businesses relating to 47 facilities, mainly in western Japan, the Company determined
that utilizing the expertise and business platform of the NSSK Group, which has extensive experience
and a strong track record in the long-term care, hospice and healthcare sectors, would contribute to the
further growth of such businesses. Accordingly, the Company and its wholly owned subsidiary, Amvis,
Inc., will each transfer the relevant businesses to the respective succeeding companies by way of
company splits and then transfer all shares in each succeeding company to NSSK-Altair1 Co., Ltd.
Through this series of transactions, the Company will further concentrate management resources and
strengthen its earnings base, while using the transfer consideration to reinforce its financial foundation
and expand capacity for growth investment. This will enable agile investment in growth areas such as the
Comprehensive Medical Support Business and is intended to enhance corporate value over the medium
to long term.
Prior to the above share transfers, the Company plans to transfer a portion of the Ishinkan business
relating to the 47 facilities (the "Transferred Business 1") to its wholly owned subsidiary, Amvis Holdings
West Japan Co., Ltd. (the "Succeeding Company"), by means of an absorption-type company split
effective November 16, 2026 (the "Company Split").
In addition, Amvis, Inc. plans to transfer a portion of the rights and obligations relating to the Ishinkan
business for the 47 facilities (the "Transferred Business 2"; together with Transferred Business 1, the
"Transferred Businesses") to the Company’s wholly owned subsidiary, Amvis West Japan Co., Ltd., by
means of an absorption-type company split effective November 1, 2026. Approval of this company split
is scheduled to be sought at the extraordinary general meeting of shareholders of Amvis, Inc. to be held
on October 29, 2026.
This Proposal seeks approval of the absorption-type company split agreement between the Company
and the Succeeding Company in connection with the Company Split described above. Approval of the
subsequent transfers of the shares of each succeeding company after the company splits is sought under
Proposal No. 2, "Approval of the Subsidiary Share Transfer Agreement."
(2) Summary of the Absorption-type Company Split Agreement
The contents of the absorption-type company split agreement relating to the Company Split are as follows.
Absorption-type Company Split Agreement (Copy)
Amvis Holdings, Inc. ("Party A") and Amvis Holdings West Japan Co., Ltd. ("Party B") hereby enter into
the following absorption-type company split agreement (this "Agreement") in order to conduct an
absorption-type company split (the "Company Split") pursuant to which Party B will succeed to the rights
and obligations held by Party A in relation to the Ishinkan business operated by Party A at the facilities
listed in Appendix 1, "Subject Facilities" (the "Business").
Article 1 (Corporate Names and Addresses of the Parties)
The corporate names and addresses of the splitting company and the succeeding company in the
Company Split are as follows.
(1) Splitting Company (Party A)
Corporate name: Amvis Holdings, Inc.
Address: 1-6-1 Kyobashi, Chuo-ku, Tokyo
(2) Succeeding Company (Party B)
Corporate name: Amvis Holdings West Japan Co., Ltd.
Address: 1-6-1 Kyobashi, Chuo-ku, Tokyo
3
Article 2 (Rights and Obligations to Be Succeeded to Through the Company Split)
- As of the Effective Date (as defined in Article 5), Party A shall cause Party B to succeed to, and Party
B shall succeed to, the assets, liabilities and contracts (including employment agreements) and other
rights and obligations held by Party A in connection with the Business, as detailed in Appendix 2,
"Schedule of Rights and Obligations to Be Succeeded to."
- Liabilities succeeded to by Party B from Party A shall be assumed by way of an assumption of debt
releasing Party A from liability.
Article 3 (Consideration to Be Delivered in Connection with the Company Split)
In connection with the Company Split, Party B shall deliver to Party A 800 common shares of Party B as
consideration for the rights and obligations succeeded to through the Company Split.
Article 4 (Increase in Capital and Reserves of Party B)
The amounts by which the stated capital and reserves of Party B will increase as a result of the Company
Split shall be determined appropriately by Party B in accordance with Article 37 or Article 38 of the
Regulation on Corporate Accounting.
Article 5 (Effective Date)
The date on which the Company Split becomes effective (the "Effective Date") shall be November 16,
- However, if necessary in light of the progress of procedures, Party A and Party B may change the
Effective Date upon consultation.
Article 6 (Approval Resolutions for the Company Split)
- Party A shall obtain approval of this Agreement at a general meeting of shareholders no later than the
Effective Date.
- Party B shall obtain approval of this Agreement at a general meeting of shareholders no later than the
Effective Date.
Article 7 (Non-compete Obligation)
Party A shall have no non-compete obligation with respect to the Business to which Party B succeeds.
Article 8 (Change in Circumstances)
If, during the period after execution of this Agreement and before the Effective Date, a material change
occurs in the assets or business condition of Party A or Party B due to a natural disaster or other cause,
a circumstance occurs that would materially impede implementation of the Company Split, or it otherwise
becomes difficult to achieve the purpose of this Agreement, Party A and Party B may, upon consultation,
change the terms of the Company Split or discontinue the Company Split.
Article 9 (Effectiveness of this Agreement)
This Agreement shall cease to be effective if any approval, permission, registration, authorization or other
action required from relevant governmental authorities for implementation of the Company Split is not
obtained.
Article 10 (Matters Not Provided for in this Agreement)
Any matters necessary in connection with the Company Split that are not provided for in this Agreement
shall be determined by Party A and Party B upon consultation in accordance with the purpose of this
Agreement.
IN WITNESS WHEREOF, two originals of this Agreement have been executed, and each party shall
retain one original.
September 28, 2026
Party A: 1-6-1 Kyobashi, Chuo-ku, Tokyo
Amvis Holdings, Inc.
Representative Director: Keiichi Shibahara [Seal]
Party B: 1-6-1 Kyobashi, Chuo-ku, Tokyo
Amvis Holdings West Japan Co., Ltd.
Representative Director: Shogo Masui [Seal]
4
Appendix 1 "Subject Facilities"
Facility Name and Address
Ama
3-1-3 Koji, Ama-shi, Aichi
Toyama
185-1
Imaizumi,
Toyama
Gifu
1-9-19 Amagasakicho, Gifu-shi, Gifu
Kakogawa
2315-1 Kitazaike, Kakogawacho,
Kakogawa-shi, Hyogo
Honjin
2-4-1 Kaminomiyacho, Nakamura-ku,
Nagoya-shi, Aichi
Ropponmatsu
1-14-16 Tani, Chuo-ku, Fukuoka-shi,
Fukuoka
Niigata
2-13-32 Meike Kamiyama, Chuo-ku,
Niigata-shi, Niigata
Hiroshima
Yokogawa
12-22
Mitakimachi,
Hiroshima-shi, Hiroshima
Niigata II
1-10-24
Abuminishi,
Niigata-shi, Niigata
Mishima
39-1 Fushimi, Shimizu-cho, Suntogun, Shizuoka
Nagano
916-1 Inaba, Nagano-shi, Nagano
Oji Koen
6-3-15 Suidosuji, Nada-ku, Kobe-shi,
Hyogo
Yokkaichi II
1-1-20 Shibata, Yokkaichi-shi, Mie
Kanazawa II
2-12-35 Izumigaoka, Kanazawa-shi,
Ishikawa
Hamamatsu
872-7
Sodecho,
Chuo-ku,
Hamamatsu-shi, Shizuoka
Okazaki
5-1 Amikasa, Ketsucho, Okazaki-shi,
Aichi
Joetsu
1698 Shimomonzen,
Niigata
Yonago
4-82 Kakubancho, Yonago-shi, Tottori
Shizuoka
821-10 Oshika, Suruga-ku, Shizuokashi, Shizuoka
Joetsu II
646-2 Kamigenni, Joetsu-shi, Niigata
Niigata III
3-1-23
Hanamizuki,
Niigata-shi, Niigata
Matsuyama
2-157-1 Chuo, Matsuyama-shi, Ehime
Fuji
82-1 Nakajima, Aza Tateborikita, Fujishi, Shizuoka
Osaka Umeda
6-25-13 Fukushima, Fukushima-ku,
Osaka-shi, Osaka
Numazu
1158
Okanomiya,
Shizuoka
Numazu-shi,
Suzuka
5-21 Suehiro Higashi, Suzuka-shi,
Mie
Yagoto Nanzan
22-11
Nanzancho,
Nagoya-shi, Aichi
Showa-ku,
Shizuoka II
5-10-20 Chiyoda, Aoi-ku, Shizuokashi, Shizuoka
Anjo
3-2-31 Imaikecho, Anjo-shi, Aichi
Ozone
4-10-17 Ozone, Kita-ku, Nagoya-shi,
Aichi
Kanazawa
2-77 Toita, Kanazawa-shi, Ishikawa
Toyota
3-24-10 Josuicho, Toyota-shi, Aichi
Tajimi
6-39 Taiheicho, Tajimi-shi, Gifu
Fujieda
1-4-14
Aobacho,
Shizuoka
Ogaki
2-26 Oi, Ogaki-shi, Gifu
Ichinomiya
5-1-14 Midori, Ichinomiya-shi, Aichi
Okayama
3-15-22 Kitanagase Omotecho, Kitaku, Okayama-shi, Okayama
Wakayama
223
Tsuhada,
Wakayama
Toyonaka
1-6-31 Tachibanacho, Toyonaka-shi,
Osaka
Takaoka
1-9-5 Habiromachi,
Toyama
Chikusa
3-13-11 Aoi, Higashi-ku, Nagoya-shi,
Aichi
Chuo-ku,
Joetsu-shi,
Higashi-ku,
Fujieda-shi,
Wakayama-shi,
Takaoka-shi,
5
Toyama-shi,
Nishi-ku,
Minami-Kusatsu
2-3-17 Oiwake Minami, Kusatsu-shi,
Shiga
Toyohashi
1-3
Minamishioda,
Toyohashi-shi, Aichi
Miyazaki
1-8-14 Takachiho-dori, Miyazaki-shi,
Miyazaki
Seki Chuo
2-6-18 Heisei-dori, Seki-shi, Gifu
Oita
1-3-18 Hatanaka, Oita-shi, Oita
Takamatsu
5013-5
Kagawa
Kitacho,
Murocho,
Takamatsu-shi,
Appendix 2 "Schedule of Rights and Obligations to Be Succeeded to"
Schedule of Rights and Obligations to Be Succeeded to
Pursuant to the absorption-type company split, the succeeding company shall succeed from the splitting
company, as of the Effective Date, to the following assets, liabilities, contracts and other rights and
obligations belonging to the Business.
The assets and liabilities included in the rights and obligations to be succeeded to shall be determined
based on the balance sheet and other calculations relating to the Business as of June 30, 2026, adjusted
for increases and decreases through the Effective Date.
- Assets
(1) The following current assets belonging to the splitting company as of the end of the day immediately
preceding the Effective Date:
(i) Advances paid relating to the Business
(ii) Prepaid expenses relating to the Business
(iii) Accounts receivable from affiliates relating to the Business
(iv) Advances paid on behalf of affiliates
(2) The following non-current and deferred assets belonging to the splitting company as of the end of the
day immediately preceding the Effective Date:
(i) Security deposits relating to the Business
(ii) Buildings relating to the Business
(iii) Building improvements relating to the Business
(iv) Structures relating to the Business
(v) Tools, furniture and fixtures relating to the Business
(vi) Land relating to the Business
(vii) Facility usage rights relating to the Business
(viii) Long-term prepaid expenses relating to the Business
- Liabilities
The following liabilities belonging to the splitting company as of the end of the day immediately preceding
the Effective Date:
(i) Accounts payable for equipment relating to the Business
(ii) Asset retirement obligations relating to the Business
(iii) Long-term borrowings relating to the Business
(iv) Accounts payable relating to the Business
(v) Accrued expenses relating to the Business
(vi) Deposits received relating to the Business
- Contracts
All contractual positions under outsourcing agreements, lease agreements, leasing agreements and all
other agreements relating to the Business that remain valid as of the end of the day immediately
preceding the Effective Date and to which the splitting company is a party, and all rights and obligations
arising under such agreements.
However, the foregoing shall exclude the contractual position under the audit agreement with the
accounting auditor and other agreements to be retained by the splitting company, and all rights and
obligations arising thereunder.
(3) Summary of the Matters Set Forth in Each Item of Article 183 of the Ordinance for Enforcement of
the Companies Act
A. Matters Concerning the Fairness of the Consideration for the Company Split
(a) Number of Shares to Be Delivered by the Succeeding Company to the Company in the Absorptiontype Company Split
In connection with the Company Split, the Succeeding Company will newly issue 800 common shares
6
and allot and deliver all of such shares to the Company.
All shares issued by the Succeeding Company as consideration will be delivered to the Company. In light
of the fact that the Succeeding Company is a wholly owned subsidiary of the Company, the number of
shares was determined through consultation between the Company and the Succeeding Company, and
the Company considers such arrangement to be fair.
(b) Amount of Increase in the Stated Capital and Reserves of the Succeeding Company as a Result of
the Absorption-type Company Split
The amounts by which the stated capital and capital reserve of the Succeeding Company will increase
as a result of the Company Split will be determined in accordance with Article 37 or Article 38 of the
Regulation on Corporate Accounting, taking into consideration the business of the Succeeding Company
after the Company Split and the assets and liabilities to be succeeded to from the Company. The
Company considers such determination to be fair.
B. Matters Concerning the Fairness of the Provisions Regarding Share Acquisition Rights
There will be no change in the treatment of share acquisition rights issued by the splitting company as a
result of the Company Split.
C. Contents of Financial Statements, etc.
Because the Succeeding Company was incorporated on September 1, 2026, As the Succeeding
Company was incorporated on September 1, 2026, it has not yet completed its first fiscal year.
The balance sheet of the Succeeding Company as of the date of incorporation is as follows.
(Millions of yen)
Assets
Liabilities and Net Assets
Current assets
0
Stated capital
Total net assets
Total assets
0
Total liabilities and net assets
0
0
0
D. Events Occurring after the End of the Company’s Most Recent Fiscal Year that Materially Affect the
Status of the Company’s Assets
At the meeting of the Board of Directors held on September 28, 2026, the Company resolved to carry out
the Company Split and a separate company split under which Amvis, Inc. will be the splitting company
and Amvis West Japan Co., Ltd. will be the succeeding company, and, after each company split, to
transfer all shares of the Succeeding Company
and Amvis West Japan Co., Ltd. to NSSK-Altair1 Co., Ltd.
(4) Events Occurring after the Incorporation of the Succeeding Company that Materially Affect the Status
of its Assets
Please refer to item D, "Events Occurring after the End of the Company’s Most Recent Fiscal Year that
Materially Affect the Status of the Company’s Assets,"
under "(3) Summary of the Matters Set Forth in Each Item of Article 183 of the Ordinance for Enforcement
of the Companies Act" above.
Proposal No. 2 Approval of the Subsidiary Share Transfer Agreement
(1) Reasons for the Share Transfer, etc.
As described in "(1) Reasons for Conducting the Absorption-type Company Split" under Proposal No. 1,
"Approval of the Absorption-type Company Split Agreement," the Company has decided, for purposes
including concentrating management resources and strengthening its earnings base, to transfer the
Transferred Businesses to the respective succeeding companies through company splits by the
Company and Amvis, Inc., and then to transfer all shares of each succeeding company.
The shares to be transferred are all shares of Amvis Holdings West Japan Co., Ltd. (the "Target Company
1"), which will succeed to Transferred Business 1, and Amvis West Japan Co., Ltd. (the "Target Company
2"; Target Company 1 and Target Company 2 are collectively referred to as the "Target Companies"),
which will succeed to Transferred Business 2.
On September 28, 2026, the Company entered into a share transfer agreement with NSSK-Altair1 Co.,
Ltd. (the "Transferee"), which is directly or indirectly invested in by investment limited partnerships and
exempted limited partnerships managed or serviced by the NSSK Group, for the transfer of all shares of
7
the Target Companies to the Transferee (the transfer, the "Share Transfer"; the agreement, the "Share
Transfer Agreement").
The Share Transfer is scheduled to be completed on November 16, 2026 in accordance with the Share
Transfer Agreement after each of the conditions precedent set forth therein has been satisfied or waived.
This Proposal seeks approval of the Share Transfer Agreement pursuant to Article 467, paragraph (1),
item (2)-2 of the Companies Act with respect to the transfer of all shares of the Target Companies
following the company splits, as part of this series of transactions.
(2) Summary of the Share Transfer Agreement
A summary of the Share Transfer Agreement is set forth below. In preparing this summary, customary
provisions and appendices have been omitted, and certain expressions have been adjusted to the extent
that the overall intent is not impaired.
Subject to the satisfaction of the conditions precedent set forth in the Share Transfer Agreement and
other applicable conditions, the Company will transfer all shares of the Target Companies held by the
Company to the Transferee on the Closing Date (November 16, 2026, or such other date as separately
agreed by the parties). Because the Share Transfer requires approval of the Company’s general meeting
of shareholders pursuant to Article 467, paragraph (1), item (2)-2 of the Companies Act, approval by
shareholders at this Extraordinary General Meeting of Shareholders is a condition precedent to the Share
Transfer.
Share Transfer Agreement
Amvis Holdings, Inc. (the "Seller") and NSSK-Altair1 Co., Ltd. (the "Buyer") hereby enter into the following
share transfer agreement (this "Agreement") as of September 28, 2026 (the "Execution Date") with
respect to the Seller’s transfer to the Buyer of the issued shares of Amvis Holdings West Japan Co., Ltd.
(the "Target Company 1") and Amvis West Japan Co., Ltd. (the "Target Company 2"; together with Target
Company 1, the "Target Companies").
Chapter 1 Definitions
Article 1.1 (Definitions)
<Omitted>
Chapter 2 Transfer of the Shares
Article 2.1 (Transfer of the Shares)
In accordance with the provisions of this Agreement, the Seller shall transfer to the Buyer 1,000 common
shares of Target Company 1 (the "Shares 1") and 200 common shares of Target Company 2 (the "Shares
2"; together with Shares 1, the "Shares"), and the Buyer shall acquire the Shares from the Seller (each
the "Share Transfer 1" and the "Share Transfer 2," respectively; together, the "Share Transfer").
Article 2.2 (Transfer Price)
- The transfer price for the Shares 1 shall be JPY 10,254 million (the "Transfer Price 1").
- The transfer price for the Shares 2 shall be the amount obtained by deducting, from JPY 7,146 million
(the "Transfer Price 2"; together with Transfer Price 1, the "Transfer Price"), the aggregate principal and
interest outstanding under the Existing Intra-group Loans as of the Closing Date.
Article 2.3 (Completion of the Transfer)
- Completion of the Share Transfer (the "Closing") shall take place on November 16, 2026, or such other
date as separately agreed by the parties (the "Closing Date"), at a location separately agreed by the
parties.
-
Chapter 3 Absorption-type Company Splits
Article 3.1 (Implementation of the Absorption-type Company Splits)
- The Seller shall enter into an absorption-type company split agreement with Amvis Holdings West
Japan Co., Ltd. (the "Target Company 1") (the "Absorption-type Company Split Agreement 1") and shall
implement the absorption-type company split contemplated thereby (the "Absorption-type Company Split
1") by the Closing Date.
- The Seller shall cause Amvis, Inc. to enter into an absorption-type company split agreement with Amvis
West Japan Co., Ltd. (the "Target Company 2") (the "Absorption-type Company Split Agreement 2";
together with the agreement referred to in paragraph 1, the "Absorption-type Company Split Agreements")
and shall cause Amvis, Inc. to implement the absorption-type company split contemplated thereby (the
"Absorption-type Company Split 2"; together with the split referred to in paragraph 1, the "Absorptiontype Company Splits") by the Closing Date.
- The Seller and the Buyer shall confirm and agree on the rights and obligations to be succeeded to
8
under the Absorption-type Company Split Agreements.
4. <Omitted>
5. If additional funds are required to operate the Target Business at Target Company 2 during the period
from the effective date of the Absorption-type Company Split 2 through the Closing Date, the Seller shall
provide certain loans (the "Existing Intra-group Loans").
Chapter 4 Conditions Precedent
Article 4.1 (Conditions Precedent to the Buyer’s Obligations)
The Buyer shall perform its obligations set forth in Article 2.3, paragraph 2 on the Closing Date subject to
the satisfaction of all conditions set forth in each item of this Article. The Buyer may, in its discretion,
waive satisfaction of any or all of the following conditions; provided, however, that any such waiver shall
not release the Seller from liability arising from the failure to satisfy the applicable condition.
(1) The Share Transfer has been approved at the general meetings of shareholders of the Target
Companies.
(2) The Seller’s representations and warranties set forth in Article 5.1 (limited to the Fundamental
Representations and Warranties) are true and correct in all material respects as of the Execution Date
and the Closing Date (or, where a specific date is stated in any item of Appendix 5.1, "Representations
and Warranties of the Seller," as of such date); provided that, where any representation or warranty is
qualified by materiality or significance, it shall be true and correct in all respects.
(3) The Seller has performed or complied in all material respects with the obligations under this
Agreement required to be performed or complied with by the Seller prior to Closing; provided that, where
any such obligation is qualified by materiality or significance, it has been performed or complied with in
all respects.
(4) As of the Closing Date, the procedures for the Absorption-type Company Splits have been lawfully
completed and the Absorption-type Company Splits have become effective or remain valid; no legal
proceedings, including actions seeking invalidation of the Absorption-type Company Splits or invalidation
or rescission of the resolutions of the Seller’s general meeting of shareholders approving them, are
pending; and no objections (other than immaterial objections) have been raised by creditors or other
interested parties.
(5) All Transferred Employees have been succeeded to by Target Company 2 through the Absorptiontype Company Split, excluding employees who have resigned from Amvis, Inc. immediately prior to the
effectiveness of the Absorption-type Company Split 2.
(6) No petition, litigation or proceeding seeking to restrict or prohibit all or any part of the Share Transfer
is pending before any judicial or administrative authority, and no law, regulation, judgment or decision of
any judicial or administrative authority exists that prohibits all or any part of the Share Transfer.
(7) Resignation letters effective as of the Closing Date have been submitted to the Target Companies by
the directors of Target Company 1 and the directors of Target Company 2 (the "Resigning Officers")
resigning as directors or corporate auditors of the Target Companies, and certified copies of such
resignation letters have been delivered to the Buyer.
(8) During the period from execution of this Agreement through Closing, no event has occurred that has,
or poses a specific and objectively reasonable risk of having, a material adverse effect on (i) the business,
assets, liabilities, financial condition, cash flows, results of operations or future earnings plans of the
Seller or the Target Companies to the extent relating to the Target Business, or (ii) the Seller’s ability to
consummate the transactions contemplated by this Agreement; provided that, even if the designation of
<Omitted> for Target Company 2 (the "Designation") has not been obtained as of the Closing Date, such
event shall not constitute an event described in this item so long as, as of the Closing Date, there is an
objective and reasonable prospect that the Designation will be obtained no later than the date separately
agreed by the Seller and the Buyer, and there is an objective and reasonable prospect that, until the
Designation is obtained, Target Company 2 can lawfully continue <Omitted> in accordance with
applicable laws and regulations through interim measures separately agreed by the Seller and the Buyer
(the "Interim Measures").
(9) All Ancillary Agreements have been duly and validly executed and remain in full force and effect in
accordance with Article 6.6.
(10) The measures for establishing the Target Companies on a standalone basis separately agreed by
the Seller and the Buyer have been completed in accordance with Article 6.7.
(11) The Required Consents have been obtained in accordance with Article 6.8, or, in lieu thereof, other
measures reasonably satisfactory to the Buyer have been completed.
<The remainder is omitted>
Article 4.2 (Conditions Precedent to the Seller’s Obligations)
The Seller shall perform its obligations set forth in Article 2.3, paragraph 3 on the Closing Date subject to
the satisfaction of all conditions set forth in each item of this Article. The Seller may, in its discretion,
waive satisfaction of any or all of the following conditions; provided, however, that any such waiver shall
9
not release the Buyer from liability arising from the failure to satisfy the applicable condition.
(1) The Buyer’s representations and warranties set forth in Article 5.2 are true and correct in all material
respects as of the Execution Date and the Closing Date (or, where a specific date is stated in any item of
Appendix 5.2, "Representations and Warranties of the Buyer," as of such date); provided that, where any
representation or warranty is qualified by materiality or significance, it shall be true and correct in all
respects.
(2) The Buyer has performed or complied in all material respects with the obligations under this
Agreement required to be performed or complied with by the Buyer prior to Closing; provided that, where
any such obligation is qualified by materiality or significance, it has been performed or complied with in
all respects.
(3) As of the Closing Date, the procedures for the Absorption-type Company Splits have been lawfully
completed and the Absorption-type Company Splits have become effective or remain valid; no legal
proceedings, including actions seeking invalidation of the Absorption-type Company Splits or invalidation
or rescission of the resolutions of the Seller’s general meeting of shareholders approving them, are
pending; and no objections (other than immaterial objections) have been raised by creditors or other
interested parties.
Chapter 5 Representations and Warranties
Article 5.1 (Representations and Warranties of the Seller)
The Seller represents and warrants to the Buyer that the matters set forth in Appendix 5.1,
"Representations and Warranties of the Seller," are true and correct as of the Execution Date and the
Closing Date (or, where a specific date is stated in any item of Appendix 5.1, as of such date).
Article 5.2 (Representations and Warranties of the Buyer)
The Buyer represents and warrants to the Seller that the matters set forth in Appendix 5.2,
"Representations and Warranties of the Buyer," are true and correct as of the Execution Date and the
Closing Date (or, where a specific date is stated in any item of Appendix 5.2, as of such date).
Article 5.3 (Knowledge of the Parties)
<Omitted>
Chapter 6 Pre-Closing Covenants
Article 6.1 (Operation of the Target Companies’ Business)
- During the period from the Execution Date (or, with respect to the Target Companies, from the effective
date of the Absorption-type Company Splits) through Closing, the Seller shall operate the Target Business
and manage its assets in accordance with past practice and with the care of a prudent manager. Except
as expressly contemplated by this Agreement or the absorption-type company split agreements relating
to the Absorption-type Company Splits, or as otherwise agreed in advance in writing with the Buyer, the
Seller shall not, and shall cause Amvis, Inc. and the Target Companies not to, take any actions with
respect to the Target Business outside the ordinary course of business that are separately agreed by the
Seller and the Buyer (in the case of the Seller and Amvis, Inc., limited to actions relating to the Target
Business).
- During the period from the Execution Date through the effective date of the Absorption-type Company
Splits, the Seller shall not cause the Target Companies to take any action except as expressly
contemplated by this Agreement or the absorption-type company split agreements relating to the
Absorption-type Company Splits, or as otherwise agreed in advance in writing with the Buyer.
Article 6.2 (Approval of the Transfer at General Meetings of Shareholders)
- The Seller shall cause the general meeting of shareholders of Target Company 1 to approve the Share
Transfer 1 no later than the Closing Date.
- The Seller shall cause the general meeting of shareholders of Target Company 2 to approve the Share
Transfer 2 no later than the Closing Date.
Article 6.3 (Resignation of Officers)
- The Seller shall cause Target Company 1 to obtain, no later than the Closing Date, resignation letters
from the Resigning Officers of Target Company 1 resigning as directors or corporate auditors of Target
Company 1 effective as of the Closing Date.
- The Seller shall cause Target Company 2 to obtain, no later than the Closing Date, resignation letters
from the Resigning Officers of Target Company 2 resigning as directors or corporate auditors of Target
Company 2 effective as of the Closing Date.
10
Article 6.4 (Delivery of Documents)
The Seller shall deliver to the Buyer certain documents, including the Seller’s certificate of seal impression,
no later than the Closing Date.
Article 6.5 (Transferred Employees, etc.)
- No later than the date on which notice is required pursuant to Article 2, paragraph (1) of the Act on the
Succession to Labor Contracts upon Company Split (the "Labor Contract Succession Act"), the Seller
shall, or shall cause Amvis, Inc. to, conduct prior consultations required by applicable laws and
regulations in connection with the Transaction with (i) employees of the Seller or Amvis, Inc. engaged in
the Target Business and (ii) employees not engaged in the Target Business whose employment
agreements with the Seller or Amvis, Inc. are specified in the Absorption-type Company Split Agreements
as being succeeded to by the Target Companies.
- No later than the date on which notice is required pursuant to Article 2, paragraph (1) of the Labor
Contract Succession Act, the Seller shall, or shall cause Amvis, Inc. to, take certain measures with the
labor unions to which the Transferred Employees belong.
-
-
Article 6.6 (Execution of Ancillary Agreements)
During the period from the Execution Date through the day immediately preceding the Closing Date, the
Seller shall, or shall cause Amvis, Inc. to, enter into with the Target Companies the agreements set forth
in each of the following items (collectively, the "Ancillary Agreements"). <Omitted>
Article 6.7 (Measures for Standalone Operation)
Following the Execution Date, the Seller shall cause the Target Companies to take the measures set
forth below for the purpose of enabling the Target Companies to continue the Target Business after the
Closing Date in substantially the same manner and by substantially the same methods as of the Execution
Date. <Omitted>
Article 6.8 (Actions with Contract Counterparties)
-
With respect to contracts and other agreements to which the Seller or Amvis, Inc. is a party and that
will be succeeded to by the Target Companies through the Absorption-type Company Splits, where such
contracts require the consent of the counterparty to consummation of the Transaction (the "Consentrequired Contracts"), the Seller shall, or shall cause Amvis, Inc. to, use commercially reasonable best
efforts to obtain, no later than the day immediately preceding the Closing Date, the written consent of
each counterparty to the transfer of the contractual position to the Target Companies through the
Absorption-type Company Splits without causing any additional costs, financial burdens or other
obligations or liabilities to arise in the Target Business (the "Required Consents"). If the Required
Consents have not been obtained by the day immediately preceding the Closing Date, the Seller shall
use commercially reasonable best efforts to obtain the outstanding Required Consents within a
reasonable period after the Closing Date or implement measures substantially equivalent thereto. The
Buyer shall cooperate to a commercially reasonable extent to facilitate the Seller’s obtaining of the
Required Consents.
-
With respect to contracts and other agreements to which the Seller or Amvis, Inc. is a party and that
will be succeeded to by the Target Companies through the Absorption-type Company Splits, where prior
notice, filing or other procedures with the counterparty are required in connection with consummation of
the Transaction (the "Notice-required Contracts"), the Seller shall, or shall cause Amvis, Inc. to, complete
the required prior notice, filing or other procedures in accordance with the terms of the applicable
contracts no later than the day immediately preceding the Closing Date.
Article 6.9 (Cooperation with Financing)
<Omitted>
Article 6.10 (Refinancing)
On the Closing Date, immediately after Closing, the Buyer shall cause the Target Companies to repay in
full the indebtedness of the Target Companies separately agreed by the Seller and the Buyer, including
by lending to the Target Companies the funds necessary for such full repayment.
<The remainder is omitted>
Article 6.11 (Target Officers and Employees)
-
During the period from the Execution Date through the Closing Date, the Seller shall use commercially
reasonable best efforts to cause the Target Officers and Employees to continue their employment with
the Seller, Amvis, Inc. or the Target Companies.
11
-
If the Seller receives or becomes aware of any written or oral notice of resignation, retirement or similar
intention from any Target Officer or Employee, the Seller shall promptly notify the Buyer thereof.
Article 6.12 (Buyer’s Access Rights, etc.)
<Omitted>
Article 6.13 (Notice of Breach of Representations and Warranties, etc.)
<Omitted>
<The remainder is omitted>
Chapter 7 Post-Closing Covenants
Article 7.1 (Appointment of Officers)
Immediately after Closing, the Buyer shall cause the Target Companies to (i) appoint the directors and
corporate auditors of the Target Companies designated by the Buyer and (ii) promptly file the registrations
relating to the appointments under item (i) and the resignations of the Resigning Officers.
Article 7.2 (Treatment of Employees)
<Omitted>
Article 7.3 (Matters Concerning Intellectual Property Rights, etc.)
-
Promptly after Closing, the Buyer shall cause the Target Companies to cease using trademarks and
other intellectual property relating to the Target Business of the Seller and Amvis, Inc. (including the
"Ishinkan" trademark; collectively, the "Trademarks, etc."); provided that the corporate names of the
Target Companies shall, as soon as practicable after Closing, be changed to names that do not include
"Amvis" or any other wording suggestive of a relationship with the Seller. <Omitted>
-
Article 7.4 (Non-compete)
For five years from the Closing Date, the Seller shall not, and shall cause its officers not to, directly or
indirectly conduct, within any prefecture in which the Target Business is operated (the "Restricted
Territory"), any business identical to the Target Business or any facility-based long-term care business
combined with a home-visit nursing office (the "Restricted Business"), nor invest in, finance, enter into
business alliances with, or acquire any interest in the Restricted Business, and shall not cause any
company, partnership, other entity or affiliate over which the Seller can reasonably exercise direct or
indirect influence on management or business activities to engage in any such act, except with the
Buyer’s prior written consent. Exceptions shall apply to the extent separately agreed by the Seller and
the Buyer in relation to the Seller’s Comprehensive Medical Support Business.
Article 7.5 (Non-solicitation)
- For five years from the Closing Date, neither the Seller nor its officers shall solicit any officer or
employee of the Buyer or the Target Companies for appointment or employment by the Seller or any
affiliate of the Seller, encourage such person to leave the Buyer or the Target Companies, or otherwise
approach such person for such purpose, and the Seller shall not cause any affiliate of the Seller to do so;
provided that voluntary applications made in response to general public recruitment shall not constitute
a violation of this Article.
- For five years from the Closing Date, neither the Buyer nor its officers shall solicit any officer or
employee engaged in the businesses of the Seller or Amvis, Inc. outside the Restricted Territory for
appointment or employment by the Buyer or the Target Companies, encourage such person to leave the
Seller or Amvis, Inc., or otherwise approach such person for such purpose, and the Buyer shall not cause
the Target Companies to do so; provided that voluntary applications made in response to general public
recruitment shall not constitute a violation of this Article.
<The remainder is omitted>
Chapter 8 Indemnification
Article 8.1 (Indemnification)
- If a party to this Agreement (the "Breaching Party") causes the other party (the "Non-breaching Party")
to incur damages, losses or expenses (including reasonable attorneys’ fees; collectively, "Losses")
arising out of or relating to any failure by the Breaching Party to perform its obligations under this
Agreement or any breach of its representations and warranties, the Breaching Party shall indemnify the
Non-breaching Party for such Losses.
- If the Non-breaching Party fails, by the date falling one year after the Closing Date (or, in the case of
a breach of an obligation under this Agreement arising after completion of the Share Transfer, six months
after the Non-breaching Party becomes aware of such breach and one year after the occurrence of such
12
breach), to make a claim for indemnification under the preceding paragraph against the Breaching Party
in writing specifying, to the extent reasonably practicable, the cause and details of the Losses, the
Breaching Party shall thereafter be released from its indemnification obligation under the preceding
paragraph; provided that this limitation shall not apply to breaches of representations and warranties or
obligations arising from the willful misconduct or gross negligence of the Breaching Party.
3. <Omitted>
Article 8.2 (Scope of Indemnification)
- With respect to indemnification for Losses under paragraph 1 of the preceding Article, if the amount of
Losses arising from a single fact is less than an amount separately agreed by the Seller and the Buyer,
the Breaching Party shall have no obligation to indemnify for such Losses arising from the applicable
failure to perform an obligation or breach of representations and warranties.
- With respect to indemnification for Losses under paragraph 1 of the preceding Article, if the aggregate
amount of indemnifiable Losses is less than an amount separately agreed by the Seller and the Buyer,
the Breaching Party shall have no obligation to indemnify for such Losses arising from the applicable
failure to perform an obligation or breach of representations and warranties.
- With respect to indemnification for Losses under paragraph 1 of the preceding Article, if the aggregate
amount of Losses arising from failures to perform obligations or breaches of representations and
warranties subject to indemnification exceeds an amount separately agreed by the Seller and the Buyer,
the Breaching Party shall, notwithstanding the preceding Article, have no obligation to indemnify the
amount exceeding such agreed amount.
- The limitations set forth in paragraphs 1 through 3 shall not apply where the Seller has engaged in
willful misconduct or gross negligence.
- With respect to claims for indemnification under paragraph 1 of the preceding Article, any amount
actually recovered by the Buyer under the representations and warranties insurance maintained by the
Buyer arising from the same event or circumstance as a breach by the Seller of this Agreement (in the
case of a breach of representations and warranties, limited to Fundamental Representations and
Warranties) shall be excluded from the Losses incurred by the Buyer or the Target Companies as a result
of such breach, and the Buyer may not, to such extent, make an indemnification claim against the Seller
on the basis that the Buyer or the Target Companies incurred such Losses.
- Notwithstanding paragraph 1 of the preceding Article, with respect to Losses incurred by the Buyer
arising from a breach of the Seller’s representations and warranties (excluding breaches of Fundamental
Representations and Warranties and fraudulent breaches), payment under the representations and
warranties insurance shall be the Buyer’s sole and exclusive remedy, and the Seller shall have no liability
whatsoever for such Losses.
Article 8.3 (Representations and Warranties Insurance)
The Buyer shall obtain, no later than the Closing Date, representations and warranties insurance on
reasonable terms and shall bear all costs arising in connection therewith.
Article 8.4 (Nature of Indemnification)
<Omitted>
Article 8.5 (Indemnification for Tax Liabilities)
Notwithstanding any other provision of this Agreement, if, as a result of the Seller’s or Amvis, Inc.’s failure
to satisfy tax obligations, the Target Companies become subject to joint and several tax payment
obligations or secondary tax payment obligations and thereby incur Losses (including the amount of tax
paid by the Target Companies under such obligations; the same applies in this Article), the Seller shall
be liable to indemnify the Target Companies for such Losses.
Article 8.6 (Special Indemnification)
Notwithstanding any other provision of this Agreement, if the Buyer incurs Losses arising out of or relating
to any of the events set forth in the following items, the Seller shall indemnify the Buyer for such Losses.
(1) Claims for medical fees made intentionally or through gross negligence by home-visit nursing stations
attached to the fee-based homes for the elderly "Ishinkan" operated as part of the Target Business that
do not comply with standards under the Health Insurance Act or other applicable laws and regulations.
(2) Certain matters relating to compliance with laws and regulations in connection with the transfer of
operations at certain facilities.
Chapter 9 Miscellaneous
<The remainder is omitted>
(The remainder of this page is intentionally left blank)
13
Appendix 5.1
Representations and Warranties of the Seller
- Representations and Warranties Concerning the Seller
(1) Legal Capacity and Authority
<Omitted>
(2) Due Completion of Transfer Procedures by the Seller
<Omitted>
(3) Enforceability
<Omitted>
(4) Acquisition and Compliance with Permits, Licenses, etc.
<Omitted>
(5) No Violation Resulting from Execution of this Agreement and the Ancillary Agreements or
Implementation of the Absorption-type Company Splits
<Omitted>
(6) Absence of Insolvency Proceedings Concerning the Seller
<Omitted>
(7) Relationship with Anti-social Forces
<Omitted>
(8) Ownership of the Shares
<Omitted>
(9) Shareholder Rights
<Omitted>
(10) Information Disclosure
<Omitted>
(11) Representations and Warranties Concerning the Target Business (in each case as of the Execution
Date and the implementation date of the Absorption-type Company Splits and limited to matters relating
to the Target Business)
<Omitted>
(i) Financial Statements
<Omitted>
(ii) Absence of Subsequent Events
<Omitted>
(iii) Acquisition of Permits and Licenses, etc.
<Omitted>
(iv) Assets Generally
<Omitted>
(v) Real Estate
<Omitted>
(vi) Intellectual Property Rights
<Omitted>
(vii) Contracts, etc.
<Omitted>
(viii) Insurance
<Omitted>
(ix) IT Systems
<Omitted>
(x) Employees
<Omitted>
(xi) Compliance with Laws and Regulations
<Omitted>
(xii) Data Protection
<Omitted>
(xiii) Litigation, etc.
<Omitted>
(xiv) Environment
<Omitted>
- Representations and Warranties Concerning the Target Companies (in each case as of the
implementation date of the Absorption-type Company Splits and the Closing Date)
(1) Due Incorporation, Valid Existence and Legal Capacity of the Target Companies
<Omitted>
(2) Acquisition and Compliance with Permits, Licenses, etc.
14
End
(3) Summary of Matters Concerning the Fairness of the Consideration to Be Received by the Company
in the Share Transfer
Matters Concerning the Fairness of the Consideration for the Share Transfer
Pursuant to the Share Transfer Agreement, the Company will transfer all shares of Amvis Holdings West
Japan Co., Ltd. and Amvis West Japan Co., Ltd. held by the Company to NSSK-Altair1 Co., Ltd. for JPY
17,400 million.
Taking into consideration the businesses, financial conditions and future outlook of Amvis Holdings West
Japan Co., Ltd. and Amvis West Japan Co., Ltd., as well as the fact that the Company and NSSK-Altair1
Co., Ltd. reached agreement on the terms of the Share Transfer price after repeated discussions and
negotiations, the Company has determined that the consideration to be received by the Company in the
Share Transfer is fair.
(4) Overview of the Subsidiaries to Be Transferred
A. Target Company 1
(1) Name
Amvis Holdings West Japan Co., Ltd.
(2) Address
1-6-1 Kyobashi, Chuo-ku, Tokyo
(3) Title and Name of
Representative
Representative Director Shogo Masui
(4) Description of Business
Operation of fee-based homes for the elderly, home-visit nursing,
home-visit care, in-home care support, welfare services for persons
with disabilities (including in-home care), consulting services,
ownership and management of real estate for facilities operated by
Amvis West Japan Co., Ltd., and other incidental businesses
(5) Stated Capital
1 yen
(6) Date of Incorporation
September 1, 2026
(7) Major Shareholder and
Shareholding Ratio
Amvis Holdings, Inc.
(8) Relationship Between the
Company and the Subject
Company
100%
Capital relationship
The Company holds 100% of the issued
shares of the subject company.
Personnel relationship
Two directors of the Company serve as
directors of the subject company.
Business relationship
Not applicable.
Related-party status
The subject company is a consolidated
subsidiary of the Company and is a related
party.
(9) Financial Position as of the Date of Incorporation
Fiscal year-end
March 31
Net assets
1 yen
Total assets
1 yen
Net assets per share
0 yen
Net sales
0 yen
Operating profit
0 yen
16
Ordinary profit
0 yen
Profit for the year
0 yen
Profit per share
0 yen
Dividend per share
0 yen
B. Target Company 2
(1) Name
Amvis West Japan Co., Ltd.
(2) Address
1-6-1 Kyobashi, Chuo-ku, Tokyo
(3) Title and Name of
Representative
Representative Director Shogo Masui
(4) Description of Business
Operation of fee-based homes for the elderly, home-visit nursing,
home-visit care, in-home care support, welfare services for persons
with disabilities (including in-home care), consulting services, and
other incidental businesses
(5) Stated Capital
1 yen
(6) Date of Incorporation
September 1, 2026
(7) Major Shareholder and
Shareholding Ratio
Amvis Holdings, Inc.
(8) Relationship Between the
Company and the Subject
Company
100%
Capital relationship
The Company holds 100% of the
issued shares of the subject company.
Personnel relationship
Two directors of the Company serve as
directors of the subject company.
Business relationship
Not applicable.
Related-party status
The subject company is a consolidated
subsidiary of the Company and is a
related party.
(9) Financial Position as of the Date of Incorporation
Fiscal year-end
March 31
Net assets
1 yen
Total assets
1 yen
Net assets per share
0 yen
Net sales
0 yen
Operating profit
0 yen
Ordinary profit
0 yen
Profit for the year
0 yen
Profit per share
0 yen
Dividend per share
0 yen
(5) Overview of the Counterparty to the Share Transfer
The transferee in the Share Transfer is NSSK-Altair1 Co., Ltd., an overview of which is set forth below.
17
(1) Name
NSSK-Altair1 Co., Ltd.
(2) Address
Atago Green Hills MORI Tower, 2-5-1 Atago, Minato-ku, Tokyo
(3) Title and Name of
Representative
Representative Director
(4) Description of Business
- Investment in companies conducting the following businesses and
companies conducting equivalent businesses:
(1) Construction
(2) Manufacturing
(3) Wholesale and retail trade
(4) Finance and insurance
(5) Real estate and goods rental and leasing
(6) Scientific research, professional and technical services
(7) Accommodation and food services
(8) Living-related and personal services and amusement services
(9) Education and learning support
(10) Medical care and welfare
(11) Various service businesses
- All businesses incidental to the foregoing
(5) Stated Capital
JPY 50,000
(6) Date of Incorporation
August 12, 2026
(7) Major Shareholder and
Shareholding Ratio
NSSK-Altair2 Co., Ltd.
(8) Relationship Between the
Company and the Subject
Company
Shohei Akiyama
100%
Capital relationship
Not applicable.
Personnel relationship
Not applicable.
Business relationship
Not applicable.
Related-party status
Not applicable.
18